• Cancel
    Date：2018-04
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=369

    Innovative Cellular Therapeutics (ICT) announced that the company had completed its Series B financing of RMB 180 million. Investors in this new round included Volcanics Venture, GTJA Investment Group, SBCVC, Dunhou Capital and Withtruth Capital. The com

  • Cancel
    Date：2018-03
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=352

    EYEGOOD OPHTHALMIC, chain brand of domestic leading ophthalmic hospital, announced that the company has completed $40 million series B financing led by CDH Investments. This is a new round of financing after series A by OrbiMed in 2015.

  • Cancel
    Date：2017-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=327

    3D Medicines, Chinese leading cancer-targeted theranostic platform company, has raised ¥670 million in a new funding round recently. The round was led by the State-Controlled Venture Capital Fund mainly sponsored by China Reform Holdings Corporation LTD.

  • Cancel
    Date：2017-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=325

    Zensun Sci & Tech (871392.OC), a leading innovative drug developer in China, announced an impressive RMB 507 million financing round yesterday, led by SDIC Venture Capital Management Co., Ltd., with a host of new backers including Tianfeng Tianrui Investm

  • Cancel
    Date：2017-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=324

    Cygnus Biosciences (Beijing) Co., Ltd., a leading domestic company focusing on developing local High-Throughput DNA sequencing platform, announced its Series B financing of RMB 130 million which was jointly led by Oriental Yirui (Shanghai) Fund and the Zh

  • Cancel
    Date：2017-09

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date：2017-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=300

    Arrail Dental Group, China's leading high-end dental care provider with close to a hundred clinics and dental hospitals, announced today that it had completed a $90 million Series D financing. The round was led by Goldman Sachs Group and Hillhouse Capita

  • Cancel
    Date：2017-06

    CEC Capital Served as Exclusive Financial Advisor

  • Cancel
    Date：2016-11

    CEC Capital Served as Exclusive Financial Advisor